MarketInOut Stock Screener Log In | Sign Up

Aquestive Therapeutics Inc

NASDAQ • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Aquestive Therapeutics Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization488.24 mln
Float110 mln
Earnings Date11/03/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-3.95
Highly reliable

Relative Strength

79 / 100
Strongly outperforming

Pre-Tax Margin

-145%
Severely loss-making

ROE

244
Extraordinary

Altman Z-Score

-3.69
Deeply distressed

Business Description

Aquestive Therapeutics is a US-based pharmaceutical company that develops and sells a range of dissolvable film medicines used to treat conditions such as epilepsy, opioid dependence, ADHD, and allergic reactions. The company's products are designed to dissolve in the mouth, offering an alternative to traditional pills or injections. Founded in 2004 and based in Warren, New Jersey, Aquestive also has several treatments in clinical trials, including a fast-acting film for severe allergic reactions and a topical gel for hair loss.

Key Fundamentals

EPS-0.66
ROE244
RPS0.45
ROIC-197
ROA-56.47
Interest Cover-3.23
EBITDA, mln-61.38
EV / EBITDA-9.11
EV / EBIT-9.03
Revenue, mln54.09
EV / Revenue10.34

Quote Details

Last 3.89
Change -0.15 (-3.71%)
Open 4.01
Volume 2,414,765
Turnover 9,393,436
Average Volume 2,087,743

Financial Ratios

Pre-Tax Profit Margin-145
Current Ratio7.19
Price / Sales8.98

Financial Strength

Altman Z-Score-3.69
Piotroski F-Score 5 / 9
Beneish M-Score-3.95
Short Ratio13.15
Short % of Float23.02

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.75% 25 / 100   
1 Month -12.39% 26 / 100   
2 Months 4.29% 82 / 100   
6 Months -7.38% 39 / 100   
1 Year -39.97% 22 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog